ORIC PHARMACEUTICALS INC ORIC

US Healthcare Pharmaceutical Preparations
$11.64
+6.9%
52w: $7.47 – $14.41

Latest 13F among current holders filed 23 days ago (Jun 12, 2026)

Price — last 12 months

research preview data
7.4710.9414.41
Jun 20, 2025 Jul 2, 2026
Institutional holders
182
+17 QoQ
13F value
$1.51B
+54.1% QoQ
Smart-money holders
31
signal tier ≥ 2
New smart buyers
5
Q1 2026
Options barometer
1.1×
$1.0M calls / $959K puts

Institutional value by quarter

$898.3M
Q1 2024
$3.34B
Q2 2024
$715.4M
Q3 2024
$611.7M
Q4 2024
$442.1M
Q1 2025
$948.7M
Q2 2025
$1.29B
Q3 2025
$979.7M
Q4 2025
$1.51B
Q1 2026

Number of holders

113
Q1 2024
113
Q2 2024
123
Q3 2024
130
Q4 2024
144
Q1 2025
143
Q2 2025
152
Q3 2025
165
Q4 2025
182
Q1 2026

Who owns ORIC?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Nextech Invest, Ltd. ★3Fundamental concentrated7.2M$90.8M6.4%Held
EcoR1 Capital, LLC ★2Fundamental concentrated6.7M$85.2M3.6%Held
BlackRock, Inc. Index provider6.0M$75.8M0.0%+1.9%
VIKING GLOBAL INVESTORS LP ★2Fundamental diversified5.8M$73.8M0.2%-11.4%
PRICE T ROWE ASSOCIATES INC /MD/ Diversified mechanical5.4M$68.3M0.0%+63.5%
SR One Capital Management, LP ★3Fundamental concentrated4.5M$58.5M6.4%Held
Pfizer Inc ★3Fundamental concentrated4.8M$57.7M24.1%-11.1%
ALKEON CAPITAL MANAGEMENT LLC ★2Fundamental diversified4.5M$57.1M0.3%Held
Venrock Adviser, LLC ★3Fundamental concentrated4.3M$54.7M2.0%-23.9%
NEA Management Company, LLC ★3Fundamental concentrated4.1M$52.2M3.0%Held
STATE STREET CORP Index provider3.7M$46.9M0.0%-13.1%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical3.7M$46.7M0.0%
Column Group LLC ★2Fundamental diversified3.5M$44.9M44.5%Held
Siren, L.L.C. ★2Fundamental diversified3.0M$38.0M1.1%+197.6%
ORBIMED ADVISORS LLC ★2Fundamental diversified2.7M$34.1M0.8%-26.0%
AIHC Capital Management Ltd ★2Fundamental diversified2.5M$31.2M26.0%New
FMR LLC Long only active2.4M$30.8M0.0%-1.8%
CITADEL ADVISORS LLC Multistrat pod2.4M$30.7M0.0%-0.5%
First Turn Management, LLC ★2Fundamental diversified2.0M$25.6M2.9%+0.3%
Vivo Capital, LLC ★3Fundamental concentrated1.8M$23.4M1.9%-12.7%
GEODE CAPITAL MANAGEMENT, LLC Index provider1.8M$23.3M0.0%+5.0%
MPM BIOIMPACT LLC ★2Fundamental concentrated1.8M$22.9M1.8%+0.3%
Paradigm Biocapital Advisors LP ★2Fundamental concentrated1.7M$21.6M0.4%-29.2%
MORGAN STANLEY Bank broker1.7M$21.3M0.0%+40.9%
GOLDMAN SACHS GROUP INC Bank broker1.5M$18.7M0.0%-23.9%
DIMENSIONAL FUND ADVISORS LP Quant stat arb1.5M$18.6M0.0%+19.9%
FRANKLIN RESOURCES INC Long only active1.5M$18.4M0.0%+19.8%
Integral Health Asset Management, LLC ★2Fundamental diversified1.4M$17.7M0.9%+16.7%
Woodline Partners LP Other1.2M$15.8M0.1%+406.0%
ROYCE & ASSOCIATES LP Other1.2M$15.3M0.2%-19.9%
BRAIDWELL LP ★2Fundamental diversified1.1M$14.3M0.5%New
SILVERARC CAPITAL MANAGEMENT, LLC ★2Fundamental diversified1.1M$13.9M1.6%-1.5%
BANK OF AMERICA CORP /DE/ Bank broker1.0M$13.2M0.0%+105.5%
Euclidean Capital LLC Wealth advisor989.4K$12.5M3.2%Held
ArrowMark Colorado Holdings LLC Other960.5K$12.2M0.3%-9.7%
EVENTIDE ASSET MANAGEMENT, LLC Other953.5K$12.1M0.2%+0.1%
Logos Global Management LP ★2Fundamental concentrated950.0K$12.0M0.6%+111.1%
Qube Research & Technologies Ltd Quant stat arb859.5K$10.9M0.0%-28.7%
Defilade Capital Management, L.P. ★2Fundamental concentrated842.9K$10.7M1.5%New
NORTHERN TRUST CORP Index provider710.9K$9.0M0.0%-19.7%
Sofinnova Investments, Inc. ★2Fundamental diversified679.6K$8.6M0.4%New
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider605.0K$7.7M0.0%-2.6%
Candriam S.C.A. Other574.1K$7.3M0.0%New
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical570.7K$7.2M0.0%
LORD, ABBETT & CO. LLC Other542.6K$6.9M0.0%-3.8%
Polar Capital Holdings Plc Other539.4K$6.8M0.0%+7.4%
SPHERA FUNDS MANAGEMENT LTD. Other537.6K$6.8M1.2%-46.5%
Balyasny Asset Management L.P. Multistrat pod523.8K$6.6M0.0%-44.9%
NEXTBio Capital Management LP ★3Fundamental concentrated523.6K$6.6M3.1%-15.0%
Connor, Clark & Lunn Investment Management Ltd. Diversified mechanical522.1K$6.6M0.0%+48.8%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.